User profiles for Taavi Päll

Taavi Päll

Researcher, Competence Centre for Cancer Research, Tallinn, Estonia
Verified email at vtak.ee
Cited by 105

[HTML][HTML] Soluble CD44 interacts with intermediate filament protein vimentin on endothelial cell surface

T Päll, A Pink, L Kasak, M Turkina, W Anderson… - PloS one, 2011 - journals.plos.org
CD44 is a cell surface glycoprotein that functions as hyaluronan receptor. Mouse and human
serum contain substantial amounts of soluble CD44, generated either by shedding or …

The therapeutic effect of Värska mud and Värska mineral water baths on the overuse pain and muscle tension syndromes in the working age population

…, M Kumm, V Tuulik, A Veraksitš, T Päll - … Geochemistry and Health, 2022 - Springer
The effects of bath therapy are complex and result from a unique interaction between the
aquatic environment and the human body functions. The effect of bath therapy depends on both …

Recombinant CD44-HABD is a novel and potent direct angiogenesis inhibitor enforcing endothelial cell-specific growth inhibition independently of hyaluronic acid …

T Päll, A Gad, L Kasak, M Drews, S Strömblad… - Oncogene, 2004 - nature.com
CD44 is the main cellular receptor for hyaluronic acid (HA). We previously found that
overexpression of CD44 inhibited tumor growth of mouse fibrosarcoma cells in mice. Here, we …

[HTML][HTML] No transmitted drug resistance to HIV integrase strand-transfer inhibitors after their scale-up in Estonia in 2017

…, R Küüsmaa, K Zilmer, K Rüütel, T Päll… - Journal of Global …, 2023 - Elsevier
Objectives In Eastern Europe, HIV-1 transmitted drug resistance (TDR) data, especially in
the integrase (IN) region, are limited. In Estonia, INSTI (integrase strand transfer inhibitors) …

[HTML][HTML] SARS-CoV-2 dual infection with Delta and Omicron variants in an immunocompetent host: a case report

…, A Shablinskaja, T Reisberg, H Niglas, T Päll… - International Journal of …, 2022 - Elsevier
Despite the high number of SARS-CoV-2 infections, only a few cases of dual infection have
been reported. Here, we describe a case of COVID-19 caused simultaneously by Delta and …

[HTML][HTML] A field-wide assessment of differential expression profiling by high-throughput sequencing reveals widespread bias

T Päll, H Luidalepp, T Tenson, Ü Maiväli - PLoS biology, 2023 - journals.plos.org
We assess inferential quality in the field of differential expression profiling by high-throughput
sequencing (HT-seq) based on analysis of datasets submitted from 2008 to 2020 to the …

Purification, characterization and plasma half-life of PEGylated soluble recombinant non-HA-binding CD44

…, A Kallastu, M Turkina, M Skolnaja, P Kogerman, T Päll… - BioDrugs, 2014 - Springer
Background and Objectives The aim of this study was to increase the serum half-life of
recombinant CD44 hyaluronan (HA) binding domain by PEGylation. We have previously found …

[PDF][PDF] Studies of CD44 Hyaluronan Binding Domain as Novel Angiogenesis Inhibitor

T PÄLL - 2013 - digikogu.taltech.ee
… was performed by Marianna Školnaja, microscopy and image preparation by Taavi Päll. …
were essentially free of detectable CD44-3MUT (Taavi Päll, unpublished results). The fate of en…

CD44 Controls Endothelial Proliferation and Functions as Endogenous Inhibitor of Angiogenesis

A Pink, M Školnaja, T Päll, A Valkna - bioRxiv, 2016 - biorxiv.org
CD44 transmembrane glycoprotein is involved in angiogenesis, but it is not clear whether
CD44 functions as a pro- or antiangiogenic molecule. Here, we assess the role of CD44 in …

Saateks

M Faster, P Päll - Eesti ja soome-ugri keeleteaduse ajakiri. Journal of …, 2020 - ojs.utlib.ee
Taavi Pae on keskendunud Hargla kihelkonna kahe eesnime – Hipp ja Mehka – levikule
ja … Osward Chanda ja Peeter Päll võrdlevad Eesti ja Sambia nimesituatsiooni ning …